Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11511001 Radiolabeled anti-LAG3 antibodies for immuno-PET imaging

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Date Filed
December 18, 2020
Date of Patent
November 29, 2022
Patent Applicant
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Patent Application Number
17127618
Patent Citations
‌
US Patent 10358495 Anti-LAG3 antibodies and uses thereof
‌
US Patent 10905784 Radiolabeled anti-LAG3 antibodies for immuno-PET imaging
‌
US Patent 10925971 Methods of treating PRLR positive breast cancer
‌
US Patent 10736976 Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging
‌
US Patent 10738124 Anti-EGFRvIII antibodies and uses thereof
‌
US Patent 10738130 Bispecific antigen-binding molecules that bind MUC16 and CD3, and compositions thereof
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11511001
Patent Primary Examiner
‌
D. L. Jones
CPC Code
‌
A61K 51/00
‌
A61K 51/08
‌
A61K 51/088
‌
A61K 51/1027
‌
A61K 51/1039
‌
A61K 51/1093
‌
A61K 39/00
‌
A61K 45/00
‌
A61K 45/06
‌
A61K 2039/505
•••

Find more entities like US Patent 11511001 Radiolabeled anti-LAG3 antibodies for immuno-PET imaging

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo